EIR Tris Pharma Jan 2014

Russell Glapion FDA$595.00 - Available Now

FDA investigators audited the Tris Pharma - Monmouth Junction, NJ, United States facility and issued inspectional observation (via FDA 483) on 21 Jan 2014.

Product details

  • Category:
  • Inspection end: 21 Jan 2014
  • Location: Monmouth Junction, United States
  • FEI: 3004712471
Add To Cart